Pharmacology Books

2392 products


  • A Textbook of Clinical Pharmacology and

    Taylor & Francis Ltd A Textbook of Clinical Pharmacology and

    1 in stock

    Book SynopsisIf you understand how drugs work (pharmacodynamics), how they are handled by the body (pharmacokinetics), how they interact with each other, and how drug treatments are assessed, then you will become a better prescriber. A Textbook of Clinical Pharmacology and Therapeutics gives you that understanding.Fully revised throughout and extensively illustrated, the fifth edition of this well-established textbook has been streamlined to focus on what medical students and junior doctors really need to know in order to understand the implications of prescribing one drug over, or in combination with, another. The text provides current information on all areas of drug prescribing with updated discussion and guidance on such topics as adverse drug reactions, ''personalized medicine'', gene and cell-based therapy, advances in cancer therapy, and mechanisms of drug action and treatment guidelines in HIV and mycobacterial infections therapy. A new chapter on alternative meTrade Review"This is an excellent source for medical students and young doctors who are learning the art of using drugs in medical practice."—Thomas L. Pazdernik (University of Kansas), Doody's Publishing Service"If you only buy one clinical pharmacology textbook for medical school, make it this one."—Oxford Medical School GazetteTable of ContentsPart 1 General principlesPart 2 The nervous systemPart 3 The musculoskeletal systemPart 4 The cardiovascular systemPart 5 The respiratory systemPart 6 The alimentary systemPart 7 Fluids and electrolytesPart 8 The endocrine systemPart 9 Selective toxicityPart 10 HaematologyPart 11 ImmunopharmacologyPart 12 The skinPart 13 The eyePart 14 Clinical toxicology

    1 in stock

    £59.99

  • The Guinea Pig Model

    Taylor & Francis Ltd The Guinea Pig Model

    15 in stock

    Book SynopsisThis book summarizes the validation of a guinea pig model for potency testing combined vaccines applied in cattle to control the respiratory, reproductive, and neonatal calf diarrhea syndromes. The model allows, in one serum sample, to test the vaccine quality for all the viral antigens included in most formulations of bovine vaccines.Table of ContentsChapter 1 - Vaccination of cattleChapter 2 - Guinea pig model to test the potency of IBR vaccinesChapter 3 - Guinea pig model to test the potency of Rotavirus vaccinesChapter 4 - Guinea pig model to test the potency of Bovine Parainfluenza Type 3 Virus vaccinesChapter 5 - Guinea pig model to test the potency of BVDV vaccinesChapter 6 - Guinea pig model applicationReferences

    15 in stock

    £41.99

  • Psychotropic Drugs and Women

    WW Norton & Co Psychotropic Drugs and Women

    1 in stock

    Book SynopsisThis is practical clinincal guide for dispensing physicians and mental health professionals who need to know the important risks and medication reactions unique to the female physiology. Readers will find information on all the key drug classes and prescription guidelines for the treatment of psychiatric disorders.

    1 in stock

    £20.89

  • Directory of Approved Biopharmaceutical Products

    Taylor & Francis Ltd Directory of Approved Biopharmaceutical Products

    Out of stock

    Book SynopsisBiopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially available products. Until now, accessing data on the list of currently approved biopharmaceuticals has been laborious and patchy.Directory of Approved Biopharmaceutical Products brings together key information on various aspects of these compounds, presenting a brief summary of each biopharmaceutical currently approved for medical use. Each summary includes the scientific and trade name, year and regions approved, approved indications, manufacturer, marketing right, method of manufacture, scientific overview, and therapeutic properties. Based on information gathered from regulatory agencies and pharmaceutical manufacturers, the book presents the most comprehensive data currently available in a single, convenient volume.This comprehensive and consistent approach will save professionals in the pharmaceutical industry hours spent trawling the literature - and provides a singular resource for future reference.Table of ContentsAntibody-based Products. Anticoagulants. Antisense Based Products. Blood Factors. Bone Morphogenetic Proteins. Colony Stimulating Factors. Erythropoietin. Growth Factors. Hormones. Interferons. Interleukins, Tumour Necrosis Factor and Related Products. Therapeutic Enzymes. Thrombolytic agents. Vaccines.

    Out of stock

    £228.00

  • Insulin Signaling From Cultured Cells to Animal

    Taylor & Francis Ltd Insulin Signaling From Cultured Cells to Animal

    Out of stock

    Book SynopsisWith contributions from the leading researchers in the field, this volume brings together the latest studies on insulin action and signal transduction to provide a state-of-the-art reference for graduate researchers and students in diabetes and endocrinology. Insulin Signaling is a comprehensive study of the regulation of molecular events by insulin at a cellular level, utilizing experimental techniques ranging from molecular systems through phenotypic expression in transgenic and knockout models.Table of ContentsStructural Aspects of the Insulin Receptor and its Downstream Effectors. Mutations in the Insulin Receptor Gene. Insulin Receptor Folding. IRS Protein Structure. Insulin Signaling Cascades. The Molecular Basis of Insulin Action. Grb-10 in Peptide Hormone Action. Regulation of Protein Kinase B: Implications for Insulin Signaling. Insulin-Mediated S6 Kinase Activation: Role in Translation Cell Growth and Insulin Production. Role of Serine/Threonine Protein Kinase Raf-1, in Insulin-Mediated Metabolic Signaling. PKC as Downstream Effector of P13 Kinase in Rat Adipocytes. Molecular Aspects of Insulin Action 10. PIKfyve and the Acute Insulin Actions. Insulin Action in Vascular Endothelium. GLUT4 Traffic Report: Molecular Mechanisms of Insulin-Stimulated GLUT4 Trafficking in Adipocytes. Insulin Receptor Trafficking. Ser/Thr Phosphorylation of Insulin Receptor Signaling Molecules and Insulin Resistance. Tyrosine Kinase Inhibitors. Abnormal p85/p110 Type PI-Kinase Activation in Zucker Fatty Rats and High-Fat Fed Rats. The Role of PKC for Insulin Receptor Signaling. Pharmacological Approaches to Insulin Resistance in the Zucker Diabetic Fatty Rat. Transgenics and Gene Knockout Models of Insulin Action. Lessons from Targeted Gene Knockouts of the Insulin receptor. Animal Models of IRS-1/IRS-2 Knockouts. Metabolic Perturbations in Mice Engineered to have Altered GLUT4 Content. Glucose Transporters and Cardiac Function: Insights from Heart Selective GLUT4 Knockout Mice. Insights from Mouse Models Deficient in Protein-Tyrosine Phosphatases that Regulate the Insulin Action Pathway.

    Out of stock

    £999.99

  • Handbook of Biotransformations of Aromatic

    Taylor & Francis Ltd Handbook of Biotransformations of Aromatic

    5 in stock

    Book SynopsisUnderstanding the biotransformations of aromatic compounds and how they metabolize in animals, plants, and microbes, is central to the applications in a wide range of industries, such as the design and testing of natural and synthetic pharmaceuticals, oil refining, the development of agrochemicals, bioremediation, and for use in functional genomics and xenobiotics. Presenting the most complete resource of its kind, the Handbook of Biotransformations of Aromatic Compounds examines 20,000 aromatic compounds researched since 1972, and assembled from all the major, relevant journals. The author focuses his coverage on the biotransformation in animals, plants, and microbes while remaining within the scope of aromatic compounds that contain, or are fused with, at least one aromatic C6 ring. Part One lists each compound alphabetically along with the forward and reverse mechanisms of its metabolism in specific organisms. Part Two characterizes the different types of organic reactions tTrade Review"The book is indispensable for my work, and for researchers involved in a variety of fields in academia and industry…The author is a world authority on the subject…I HIGHLY recommend this book…" - Dr. Iqbal Gill, Head of Biotransformations/Biocatalysis Department, Roche Vitamins Inc."…a well-structured book covering the literature of the last thirty years….easy to use and contains plenty of interesting material…contains an immense amount of information on themetabolism of aromatic compounds." ChemBioChem 2005, volume 6 "This book is an excellent and exhaustive source…a labour of love which should prove to be an essential reference source for those involved in the biotransformation of aromatics as it provides detailed coverage of developments within this field over the past 100 years." biochemist.org, July 8, 2005Table of ContentsReactions Involving the Formation and Degradation of The Aromatic Nucleus. Oxidations and Reductions Involving the Aromatic Nucleus and Non-Organic Substituents. Oxidations and Reductions of Substituent Side Chains and Non-Aromatic Ring Systems (Without Altering Chain Length). Formation and Degradation of Side-Chains. Side-Chain Formation. Conjugation and Substitution Reactions. Elimination of Substituents. Transfer Reactions. Formation and Reactions of Non-Aryl Double and Triple Bonds. Hydration of Epoxides. Light-Forming Reactions.

    5 in stock

    £913.45

  • Proteinase and Peptidase Inhibition Recent

    Taylor & Francis Ltd Proteinase and Peptidase Inhibition Recent

    1 in stock

    Book SynopsisCellular proteinases and their physiological role in normal and disease states have been the subject of great interest over recent decades. At present, specific protease inhibitors are exploited both as tools in unraveling the role of individual proteinases in particular cellular processes and for the development of chemotherapeutic agents for the treatment of various disorders. Proteinase and Peptidase Inhibition presents updated progress reports on the characterization of a wide range of cellular proteinases whose inhibitors may hold the key to the development of new drugs. Introductory chapters deal with the broad enzyme classes, inhibitor types and regulatory mechanisms governing proteinase activity. The target enzymes themselves, together with all aspects of their inhibition and inhibitor design, are comprehensively described. The classification of target enzymes by structural similarity, rather than by pharmacological effects, provides a new and coherent platform for understandinTable of ContentsEnzyme Classes and Mechanisms. Regulatory Mechanisms for Proteinase Activity. Matrix Metalloproteinases (MMPs). Proteasomes. Cathepsins. Calpain. Human Neutrophil Elastase Inhibitors. Thrombin. Inhibitors of Factor VIIa, Factor IXa, and Factor Xa as Anticoagulants. The Urokinase-Type Plasminogen Activator (uPA) System: A New Target for Tumor Therapy. Proteinases Involved in Amyloid ß-Peptide (Aß) Production and Clearance. Herpes Virus and Cytomegalovirus Proteinase. Human Rhinovirus 3C Proteinase Inhibitors. Aminopeptidases. The Hepatitis C Virus NS3 Serine-Type Proteinase. Zinc Metallopeptidases. HIV Aspartate Proteinase: Resistance to Inhibitors. Proteases of Protozoan Parasites for Proteinase Activity.

    1 in stock

    £220.00

  • Genetics of Steroid Biosynthesis and Function

    Taylor & Francis Ltd Genetics of Steroid Biosynthesis and Function

    Out of stock

    Book SynopsisSteroids are among the most widely prescribed drugs for humans, and steroid signaling pathways are present in vertebrates, plants, insects and fungi, presenting new avenues for biotechnological intervention. Genetics of Steroid Biosynthesis and Function focuses on the genetic and cellular aspects of mammalian steroid hormones with particular attention to inherited gene lesions. With contributions from a panel of international experts, this volume provides an accessible, up-to-date overview of modern steroid biology for both the professional and novice researcher alike.Table of ContentsSteroid Biosynthesis: Enzymology, Integration and Control. Sterol Biosynthesis. Vitamin D Biosynthesis and its Disorders. Bile Acid Biosynthesis. Cholesterol Metabolism in Steroidogenic Tissues. Steroid 21-Hydroxylase. Steroid 11ß-Hydroxylase Isozymes. 3ß-Hydroxysteroid Dehydrogenase/ Isomerase Deficiency. Human 17a-Hydroxylase/17, 20-Lyase. Aromatase: Insights into the Roles of Estrogens Revealed by Natural and Targeted Mutations. 17ß-Hydroxysteroid Dehydrogenase and 5a-Reductase Deficiencies. Steroid Metabolism in Peripheral Tissues. Animal Models of Impaired Steroidgenesis. Regulation of Gene Expression by the Nuclear Receptor Family. Neurosteroids and Brain Sterols.

    Out of stock

    £194.75

  • Shengmai San

    Taylor & Francis Ltd Shengmai San

    15 in stock

    Book SynopsisTraditional Chinese medicine commonly prescribes herbal formulas for the prevention and treatment of diseases. Shengmai San, a famous Chinese medicinal formula that has been used for more than eight hundred years in China, is comprised of Radix Ginseng, Fructus Schisandre and Radix Ophiopogonis. Traditionally, Shengmai San is used for the treatment of excessive loss of essence Qi and body fluid that threaten heart failure, particularly in the summer when heat exhaustion and profuse sweating commonly occur. This book provides a comprehensive treatise on the historical, phytochemical, pharmacological/toxicological, clinical as well as pharmaceutical aspects of Shengmai San and its component herbs.Table of Contents1. Shengmai San - A Renowned Traditional Chinese Medicine 2. Pharmacological Studies on Shengmai San 3. Clinical Studies on Shengmai San 4. Side Effects of Shengmai San 5. Phytochemistry and Pharmacology of Component Herbs of Shengmai San 6. Contemporary Applications of a Traditional Formula: Manufacturing of Shengmai San (SMS) Preparations and their Applications Duncan H.F. Mak, Hong Kong University of Science and Technology, Jie Chen, Shanghai Second Medical University, China, Kam-Ming Ko, Hong Kong University of Science and Technology, Liang-Yuan Zheng, Livzon Pharmaceutical Group, China, Mei-Hua Zhao, Shanghai Second Medical University, China, Shang-Biao Lu, Shanghai Second Medical University, China, Shu-Ying Chen, Guangzhou University of Traditional Medicine, China, Si-Qian Liang, Guangzhou University of Traditional Medicine, China, Siu-Po Ip, The Chinese University of Hong Kong, Song-Ming Liang, Guangzhou University of Traditional Medicine, China, Timothy C.M. Tam, The Chinese University of Hong Kong, Tze-Kin Yim, Hong Kong University of Science & Technology, Xiang-Yang Zhu, Shanghai Second Medical University, China, Ya-Chen Zhang, Shanghai Second Medical University, China, Ye-Zhi Rong, Shanghai Second Medical University, China, Yong-Qing Yan, The China Pharmaceutical University, Yun-Cheung Kong, The Chinese University of Hong Kong, Zhi-Min Xu, Shanghai Second Medical University, China

    15 in stock

    £175.00

  • Endocannabinoids The Brain and Bodys Marijuana

    Taylor & Francis Ltd Endocannabinoids The Brain and Bodys Marijuana

    Out of stock

    Book SynopsisOver the past decade, there have been major advances in understanding the mechanisms whereby marijuana interacts with the brain in producing psychoactive and potentially therapeutic effects. The discovery of specific gene coding for cannabinoid receptors activated by smoking marijuana, and the finding of endogenous cannabinoids, which also activate the receptors, have transformed cannabinoid research into mainstream science with significant implications in human health and diseaseEndocannabinoids: The Brain and Bodyâs Marijuana and Beyond documentsadvances in the discovery and functioning of naturally occurring marijuana-like substances in human biology. It explores recent findings that point to the existence of an endocannabinoid physiological control system (EPCS) that directly impacts human development, health, and disease. While cannabinoid effects on the brain have received the greatest attention throughout the literature, this work looks at research on the endogenous cannabinoid systemâs association across all of human physiology, including the immune, endocrine, and reproductive systems. With thoroughly researched and exceptionally insightful contributions from more than three-dozen top-flight researchers representing a cross-section of disciplines from molecular biology, genetics, and neurology to gynecology, physiology, and pharmacology, this work explores a range of topics as wide as the human body is complex. These topics include the EPCSâs relation to cell development and regulation, CNS function, immune function modulation, reproduction, and digestion, as well as its function in mental illness, neurodegenerative diseases, and cancer. The final section in the book considers the significance of endogenous cannabinoids found in some of the simplest multicellular organisms in the animal kingdom, as well as in mammalian cells at the earliest stages of development, all of which suggests that they play a fundamental role in human biology.Table of ContentsHistorical Aspects and Chemistry. Genetics, Signaling and Receptors. Biochemistry of the Endocannabinoid System. Endocannabinoids in CNS Physiology. Endocannabinoids in CNS Pathology. Endocannabinoids in Peripheral Organ Systems. Endocannabinoids in Non-Mammals. Perspective.

    Out of stock

    £204.25

  • Neurobiology of DOPA as a Neurotransmitter

    Taylor & Francis Ltd Neurobiology of DOPA as a Neurotransmitter

    15 in stock

    Book SynopsisNew research suggests it is highly probable that DOPA, in addition to being a precursor to dopamine, functions by itself as a neurotramsmitter and/or neuromodulator. Neurobiology of DOPA as a Neurotransmitter integrates background information about DOPA as an inert amino acid precursor of dopamine with the evidence showing that DOPA fulfills several criteria of neurotransmitters. Providing easy access to, and complete understanding of, the latest research on the subject, the book makes the case that DOPA meets many of the criteria of neurotransmitters and includes anti-evidence in some instances.The book begins with a historical review of current knowledge of DOPA. It characterizes DOPA as a prominent example showing transmutation from an inert substance to a gold drug in Parkinson's disease and further to a neurotransmitter in its own right. The next chapters cover the essential criteria of a neurotransmitter such as synthesis, existence, and competitive anTrade Review"…a highly detailed review of antipsychotic drugs and neuroreceptors. There are many reviews of psychopharmacology, but this is one of the most specialized and exhaustive I have read. Any clinician or researcher interested in antipsychotic medications would find it a useful addition to their library."-William Miles, M.D., Rush-Presbyterian-St. Luke's Medical Center "The editors have succeeded well in their objective: to begin bridge the gap between the lab and the clinic. Dopamine, dopamine receptors, and dopamine transport lie at the core of important human disorders such as schizophrenia and Parkinson's disease. 4 Stars!"- Daniel B. Hier, MD, University of Illinois at Chicago College of Medicine, for Doody's Review"… present a timely overview of the different aspects of this amino acid in neurotransmission. … written by over 40 leading experts … a must-read for every neuroscientist working on endogenous neurotransmitters." – Karl Gademann, Switzerland in ChemMedChem, 1, 2006Table of ContentsHistory. Biosynthesis, Metabolism, Active Transport, and Existence. Release. Pharmacology. Neurotoxicology. Index.

    15 in stock

    £292.96

  • Elsevier Health Sciences Mosbys Drug Guide for Nursing Students

    Out of stock

    Book Synopsis

    Out of stock

    £37.99

  • Nuclear Receptors in Drug Metabolism

    John Wiley & Sons Inc Nuclear Receptors in Drug Metabolism

    1 in stock

    Book SynopsisProviding an updated and expert overview of nuclear hormone receptors in drug metabolism and drug development, this book equips drug development scientists with an interdisciplinary understanding of these receptors and how to regulate them.Table of ContentsPreface. Abbreviations. Contributors. Chapter 1. Drug Metabolism: Significance and Challenges (Chandra Prakash and Alfin D.N. Vaz). 1.1. Introduction. 1.2. Phase I Drug Metabolizing Enzymes. 1.3. Phase II Conjugative Enzymes. 1.4. Drug Efflux Transporters. 1.5. Drug Uptake Transporters. 1.6. Challenges in Drug Metabolism. 1.7. Summary. 1.8. References. Chapter 2. Establishing Orphan Nuclear Receptors PXR and CAR as Xenobiotic Receptors (Tao Li, Junichiro Sonoda, and Ronald M. Evans). 2.1. Introduction. 2.2. Nuclear Receptor and Orphan Nuclear Receptor Superfamily. 2.3. Orphan Nuclear Receptors as Xenobiotic Receptors and Their Implications in Phase I Enzyme Regulation. 2.4. Perspectives. 2.5. References. Chapter 3. Nuclear Receptor-Mediated Regulation of Phase II Conjugating Enzymes (Olivier Barbier). 3.1. Introduction. 3.2. Phase II Drug Metabolizing Enzymes. 3.3. The Xenosensors CAR and PXR: 2 Masters Regulators of Phase II Metabolism. 3.4. AhR And Nrf2, Two Important Regulators of Phase II Enzymes. 3.5. PPARS and Phase II XMEs Regulation. 3.6. FXR/LXR and Phase II XMEs Regulation. 3.7. HNF and Phase II XMEs Regulation. 3.8. Regulation of Phase II Conjugating Enzymes by Steroid and Thyroid Receptors. 3.9. Concluding remarks and perspectives. 3.10. References. Chapter 4. Nuclear Receptor-Mediated Regulation of Drug Transporters (Oliver Burk). 4.1. Introduction. 4.2. Drug Transporters. 4.3. Induction of Drug Transporters by Activation of PXR and CAR. 4.4. Induction of Drug Transporters by Activation of PPARa. 4.5. Molecular Mechanism of PXR- and CAR-Dependent Drug Transporter Regulation. 4.6. Induction of Drug Transporter Expression and Drug Disposition. 4.7. Conclusions and Future Perspectives. 4.8. References. Chapter 5. Structure and Function of PXR and CAR (X. Edward Zhou and H. Eric Xu). 5.1. Introduction. 5.2. Structure and Function of PXR. 5.3. Structure and Function of CAR. 5.4. Concluding Remarks. 5.5. References. Chapter 6. Xenobiotic Receptor CoFactors and Coregulators (John Y. L. Chiang). 6.1. Regulation of PXR and CAR Nuclear Translocation. 6.2. Nuclear Receptor Coregulators and Epigenetic Regulation of Gene Transcription. 6.3. PXR and CAR Crosstalk with other Nuclear Receptors and Transcription Factors. 6.4. PXR and CAR Regulation of Lipid and Glucose Homeostasis. 6.5. Conclusion. 6.6. References. Chapter 7. Animal Models of Xenobiotic Nuclear Receptors and Their Utility in Drug Development (Haibiao Gong and Wen Xie). 7.1. Introduction. 7.2. PXR and CAR Loss-of-Function (Knock Out) Mouse Models. 7.3. PXR and CAR Gain-of-Function (Transgenic) Mouse Models. 7.4. Humanized Mouse Models. 7.5. Utility of Xenobiotic Mouse Models in Pharmaceutical Development. 7.6. Closing Remarks. 7.7. References. Chapter 8. Nuclear Receptors and Drug-Drug Interactions with Prescription Drugs and Herbal Medicines (Rommel G. Tirona and Richard B. Kim). 8.1. Introduction. 8.2. Prescription Drugs/Drug Classes Commonly Involved in Inductive Interactions. 8.3. Herbal Drug Medicines Commonly Involved in Inductive Interactions. 8.4. Pharmacology of Induction. 8.5. Clinical Aspects of Induction-Type Drug Interactions. 8.6. Inhibition of Nuclear Receptors in Clinical Drug Interactions. 8.7. Nuclear Receptor-Mediated Drug Side-Effects. 8.8. Perspectives. 8.9. References. Chapter 9. Genetic Variants of Xenobiotic Receptors and Their Implications in Drug Metabolism and Pharmacogenetics (Jatinder Lamba and Erin G. Schuetz). 9.1. PXR (Pregnane X Receptor) Background. 9.2. PXR Gene Structure. 9.3. PXR Alternative mRNAs. 9.4. Genetic Variants in PXR’s Exons and their Functional Consequences. 9.5. Genetic Variants In Introns 2-8 and the 3’-UTR of PXR and their Functional Consequences. 9.6. Resequencing Strategy for the PXR Promoter and Intron 1. 9.7. Genetic Variation in the PXR Promoter and 5’-UTR and its Functional Relevance. 9.8. Genetic Variation in PXR’s Intron 1 and its Functional Relevance. 9.9. In Silico Analysis for Functional Effect of SNPs in PXR’s Promoter, 5’-UTR and Intron 1. 9.10. SNPs in PXR’s Promoter and Intron 1 Affect Putative HNF Binding Sites. 9.11. PXR SNPs Have Been Associated with Intestinal and Hepatic Inflammation and Diseases. 9.12. PXR Structural Variation and other Genomic Features. 9.13. PXR Summary. 9.14. CAR-Background. 9.15. CAR Gene Structure. 9.16. CAR Alternatively Spliced RNAs. 9.17. CAR Genetic Variants (SNPs) and their Functional Consequences. 9.18. CAR Summary. 9.19. References. Chapter 10. Beyond PXR and CAR, Regulation of Xenobiotic Metabolism by Other Nuclear Receptors (Martin Wagner, Gernot Zollner, and Michael Trauner). 10.1. Introduction. 10.2. Farnesoid X Receptor. 10.3. Hepatocyte Nuclear Factor 4. 10.4. Vitamin D receptor. 10.5. Glucocorticoid Receptor. 10.6. Peroxisome Proliferator Activated Receptors. 10.7. Aryl Hydrocarbon Receptor (AhR). 10.8. Conclusions. 10.9. References. Chapter 11. Emerging Role of Retinoid-Related Orphan Receptor (ROR) and Its Crosst alk With LXR(Liver X Receptor) in the Regulation Of Drug-Metabolizing Enzymes (Taira Wada and Wen Xie). 11.1. Introduction. 11.2. Orphan Nuclear Receptor RORα. 11.3. A Potential Role of RORs in Xeno- and Endobiotic Gene Regulation. 11.4. LXR and its Regulation of Drug Metabolizing Enzymes. 11.5. A Functional Cross-Talk Between RORa and LXR in the Regulation of Xeno- and Endobiotic Genes. 11.6. Closing Remarks. Index.

    1 in stock

    £105.26

  • Pathway Analysis for Drug Discovery

    John Wiley & Sons Inc Pathway Analysis for Drug Discovery

    1 in stock

    Book SynopsisThis book introduces drug researchers to the novel computational approaches of pathway analysis and explains the existing applications that can save time and money in the drug discovery process. It covers traditional computational methods and software for pathway analysis microarray, proteomics, and metabolomics.Trade Review"Pathway analysis will help lead to a better understanding of the chemistry of living systems and the aberrations that disrupt health. This new book will serve as a beacon to research interested in this field." (Journal of Medicinal Chemistry, April 9, 2009)Table of ContentsPreface. Contributors. 1 Introduction to Pathway Analysis (Anton Yuryev). 2 Software Infrastructure and Data Model for Pathway Analysis (Fedor Bokov and Anton Yuryev). 3 Automatic Pathway Inference in Heterogeneous Biological Association Networks (Anton Yuryev, Andrey Kalinin, and Nikolai Daraselia). 4 Algorithmic Basis for Pathway Visualization (Sergey Simakov, Iaroslav Ispolatov, Sergei Maslov, and Alexander Nikitin). 5 Pathway Analysis of High-Throughput Experimental Data (Andrey Y. Sivachenko). 6 Integrative Pathway Analysis of Disease Molecular Data (Andrej Bugrim, Zoltan Dezso, Yuri Nikolsky, and Tatiana Nikolskaya). 7 Whole-Genome Expression Profi ling of Papillary Serous Ovarian Cancer: Activated Pathways, Potential Targets, and Noise (John Farley, Laurent L. Ozbun, and Michael J. Birrer). 8 Mammalian Proteome and Toxicant Network Analysis (Sean Ekins and Craig N. Giroux). 9 Unraveling Mechanisms of Toxicity with the Power of Pathways: ToxWiz Tool as an Illustrative Example (Mark P. Kühnel, Bojana Cosovic, Goran Medic, Robert B. Russell, and Gordana Apic). 10 Impact of Chemistry Information on Pathway Analysis (Sreenivas Devidas). 11 Propagation of Concentration Perturbations in Equilibrium Protein Binding Networks (Sergei Maslov and Iaroslav Ispolatov). 12 An Adaptive System Model of the Yeast Glucose Sensor System (Todor Vujasinovic and André Siniša Žampera). 13 Present and Future of Pathway Analysis in Drug Discovery (Anton Yuryev). Index.

    1 in stock

    £105.26

  • DrugInduced Mitochondrial Dysfunction

    John Wiley & Sons Inc DrugInduced Mitochondrial Dysfunction

    1 in stock

    Book SynopsisThis is the definitive, one-stop resource on preclinical drug evaluation for potential mitochondrial toxicity, addressing the issue upfront in the drug development process. It discusses mitochondrial impairment to organs, skeletal muscle, and nervous systems and details methodologies used to assess mitochondria function. It covers both in vitro and in vivo methods for analysis and includes the latest models. This is the authoritative reference on drug-induced mitochondrial dysfunction for safety assessment professionals in the pharmaceutical industry and for pharmacologists and toxicologists in both drug and environmental health sciences.Table of ContentsContributors. Preface. Part I: Basic Concepts. 1. Basic Mitochondrial Physiology in Cell Viability and Death (Lech Wojtczak and Krzysztof Zabtocki). 2. Basic Molecular Biology of Mitochondrial Replication (Immo E. Scheffler). 3. Drug-Associated Mitochondrial Toxicity (Rhea Mehta, Katie Chan, Owen Lee, Shahrzad Tafazoli, and Peter J. O'Brien). 4. Pharmacogenetics of Mitochondrial Drug Toxicity (Neil Howell and Corinna Howell). Part II: Organ Drug Toxicity: Mitochondrial Etiology. 5. Features and Mechanisms of Drug-Induced Liver Injury (Dominique Pessayre, Alain Berson, and Bernard Fromenty). 6. Cardiovascular Toxicity of Mitochondrial Origin (Paulo J. Oliveira, Vilma A. Saradao, and Kendall B. Wallace). 7. Skeletal Muscle and Mitochondrial toxicity (Timothy E. Johnson). 8. Manifestations of Drug Toxicity on Mitochondria in the Nervous System (Ian J. Reynolds). 9. Lipoatrophy and Other Manifestations of Antiretroviral Therapeutics (Ulrich A. Walker). 10. Nephrotoxocity (Alberto Ortiz, Alberto Tejedor, and Carlos Caramelo). 11. Drug Effects in Patients with Mitochondrial Diseases (Eric A. Schon, Michio Hirano, and Salvatore DiMauro). Part III: Assessment of Mitochondrial Function in Vitro and In Vivo. 12. Polarographic Oxygen Sensors, the Oxygraph, and High-Resolution Respirometry to Assess Mitochondrial Function (Erich Gnaiger). 13. Use of Oxygen-Sensitive Fluorescent Probes for the Assesment of Mitochondrial Function (James Hynes, Tomas C. O'riordan, and Dmitri B. Papkovsky). 14. Mitochondrial Dysfunction Assessed Quantitatively in Real Time by Measuring the Extracellular Flux of Oxygen and Protons (David Ferrick, Min Wu, Amy Swift, and Andy Neilson). 15. Assessment of Mitochondrial Respiratory Complex Function In Vitro and In Vivo (Mark A. Birch -Machin). 16. OXPHOS Complex Activity Assays and Dipstick Immunoassays for Assessment of OXPHOS Protein Levels (Sashi Nadanaciva). 17. Use of Fluorescent Reporters to Measure Mitochondrial Membrane Potential and the Mitochondrial Permeability Transition (Anna Liisa Nieminen, Benkat K. Ramshesh, and John L. Lemasters). 18. Compartmentation of Redox Signaling and Control: Discrimination of Oxidative Stress in Mitochondria, Cytoplasm, Nuclei, and endoplasmic Reticulum (Patrick J. Halvey, Jason M. Hansen, Lawrence H. Lash, and Dean P. Hones). 19. Assessing Mitochondrial Protein Synthesis in Drug Toxicity Screening (Edward E. McKee). 20. Mitochondrial Toxicity of Antiviral Drugs: A Challenge to Accurate Diagnosis (Michel P. de Baar and Anthony de Ronde). 21. Clinical Assessment of Mitochondrial Function via [13C]Methionine Exhalation (Laura Milazzo). 22. Assessment of Mitochondrial Dysfunction by Microscopy (Ingrid Pruimboom-Brees, Germaine Boucher, Amy Jakowski, and Jeanne Wolfgang). 23. Development of Animal Models of Drug-Induced Mitochondrial Toxicity (Urs A. Boelsterli and Yie Hou Lee). 24. Noninvasive Assessment of Mitochondrial Function Using Nuclear Magnetic Resonance Spectroscopy (Robert W. Wiseman and J.A. L. Jeneson). 25. Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations (Michael P. Murphy). Index.

    1 in stock

    £155.66

  • Combating the Threat of Pandemic Influenza

    John Wiley & Sons Inc Combating the Threat of Pandemic Influenza

    Out of stock

    Book SynopsisDrug discovery for influenza antivirals Priorities for combating pandemic influenza include rapid detection and identification, the quick administration of available drugs to treat the infection, the development of new antivirals, and the development of vaccines. Since lead-time may be required to produce an effective vaccine, antivirals would serve as a key first line of defense in containing an outbreak. Diverse antivirals, acting through different mechanisms, would help stay the development of resistant viruses. Thus, drug discovery for influenza antivirals is an important public healthrelated endeavor. With chapters contributed by leading international specialists, this guide gets readers up to speed on the latest advances and technologies in diverse approaches to drug discovery, covering: Existing antivirals, including broadly effective anti-respiratory virus agents The development of high-throughput screening assays IFN resisTable of ContentsContributors. Preface. 1. Existing Influenza Antivirals: The Mechanisms of Action and Potential in the Face of Avian Influenza (Erik De Clercq). 2. Development of High-Throughput Screening Assays for Influenza (Diana L. Noah, E. Lucile White, and James W. Noah). 3. Mechanisms of IFN Resistance by Influenza Virus (Heather J. Ezelle and Bret A. Hassel). 4. Broadly Effective Anti-Respiratory Virus Agents (Shiro Shigeta). 5. Current Status on Development of Nucleic Acid-based Antiviral Drugs Against Influenza Virus Inefection (Jonathan P. Wong, Mary E. Christopher, Murray Cairns, L.-Q. Sun, Roderic M.K. Dale, and Andres M. Salazar). 6. Antiviral RNA Interface Strategies Targeting Influenza Virus and Other Respiratory Viruses (Joost Haasnoot and Ben Berkhout). 7. Promising Antiviral Glyco-molecules from an Edible Alga (Toshimitsu Hayashi, Kyoko Hayashi, Kenji Kanekiyo, Jung-Bum Lee, Takahisa Nakano, and Minoru Hashimoto). 8. Rational Design of an Anti-Adhesion Drug for Influenza (Nicolai V. Bovin and Alexandra S. Gambaryan). 9. Understanding Influenza Neuraminidase Inhibitors Using Quantitative Structure - Activity Relationship (QSAR) Models (Rajeshwar P. Verma and Corwin Hansch). 10. Peptide Inhibitors Targeting Virus-Cell Fusion in Class 1 Enveloped Viruses (George F. Gao). 11. Novel Influenza Therapeutics (Laura M. Aschenbrenner, Nicole Pelletier, Mang Yu, and Fang Fang). Index.

    Out of stock

    £137.66

  • Modern Tools for the Synthesis of Complex

    John Wiley & Sons Inc Modern Tools for the Synthesis of Complex

    4 in stock

    Book SynopsisAn overview of the new technologies that have revolutionized organic chemistry and allowed easy access to complex bioactives, this book brings modern synthetic techniques and bioactives together. The synthesis of structurally complex molecules has become a real challenge for the synthetic community.Table of ContentsFOREWORD vii PREFACE ix CONTRIBUTORS xi CHAPTER 1 C–H FUNCTIONALIZATION: A NEW STRATEGY FOR THE SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS 1 Sophie Rousseaux, Benoýˆt Lie´gault, and Keith Fagnou CHAPTER 2 THE NEGISHI CROSS-COUPLING IN THE SYNTHESIS OF NATURAL PRODUCTS AND BIOACTIVE MOLECULES 33 Evelina Colacino, Jean Martinez, and Fre´de´ric Lamaty CHAPTER 3 METAL-CATALYZED C–HETEROATOM CROSS-COUPLING REACTIONS 77 Renata Marcia de Figueiredo, Jean Marc Campagne, and Damien Prim CHAPTER 4 GOLDEN OPPORTUNITIES IN THE SYNTHESIS OF NATURAL PRODUCTS AND BIOLOGICALLY ACTIVE COMPOUNDS 111 Fabien Gagosz CHAPTER 5 METATHESIS-BASED SYNTHESIS OF COMPLEX BIOACTIVES 155 Jean-Alexandre Richard, Sin Yee Ng, and David Y.-K. Chen CHAPTER 6 ENANTIOSELECTIVE ORGANOCATALYSIS: A POWERFUL TOOL FOR THE SYNTHESIS OF BIOACTIVE MOLECULES 189 Mitsuru Shoji and Yujiro Hayashi CHAPTER 7 ASYMMETRIC PHASE-TRANSFER CATALYSIS 213 Seiji Shirakawa, Shin A. Moteki, and Keiji Maruoka CHAPTER 8 REARRANGEMENTS IN NATURAL PRODUCT SYNTHESIS 243 Jose´ Marco-Contelles and Elena Soriano CHAPTER 9 DOMINO REACTIONS IN THE ENANTIOSELECTIVE SYNTHESIS OF BIOACTIVE NATURAL PRODUCTS 271 Lutz F. Tietze, Scott G. Stewart, and Alexander Du¨fert CHAPTER 10 FLUOROUS LINKER-FACILITATED SYNTHESIS OF BIOLOGICALLY INTERESTING MOLECULES 335 Wei Zhang CHAPTER 11 THE EVOLUTION OF IMMOBILIZED REAGENTS AND THEIR APPLICATION IN FLOW CHEMISTRY FOR THE SYNTHESIS OF NATURAL PRODUCTS AND PHARMACEUTICAL COMPOUNDS 359 Rebecca M. Myers, Kimberley A. Roper, Ian R. Baxendale, and Steven V. Ley CHAPTER 12 SYNTHETIC APPROACHES TO BIOACTIVE CARBOHYDRATES 395 Xavier Guinchard, Se´bastien Picard, and David Crich CHAPTER 13 AMMONIUM YLIDES AS BUILDING BLOCKS FOR ALKALOID SYNTHESIS 433 Scott Bur and Albert Padwa CHAPTER 14 PRECURSOR-DIRECTED BIOSYNTHESIS OF POLYKETIDE AND NONRIBOSOMAL PEPTIDE NATURAL PRODUCTS 485 Colin J. B. Harvey and Chaitan Khosla CHAPTER 15 TARGET-ORIENTED AND DIVERSITY-ORIENTED ORGANIC SYNTHESIS 513 Raphae¨l Rodriguez CHAPTER 16 DNA AS A TOOL FOR MOLECULAR DISCOVERY 539 Michael Smietana, Jean-Jacques Vasseur, Janine Cossy, and Stellios Arseniyadis INDEX 557

    4 in stock

    £128.66

  • Drug Delivery Applications of Noninvasive Imaging

    John Wiley & Sons Inc Drug Delivery Applications of Noninvasive Imaging

    2 in stock

    Book SynopsisCost-effective strategies for designing novel drug delivery systems that target a broad range of disease conditions In vivo imaging has become an important tool for the development of new drug delivery systems, shedding new light on the pharmacokinetics, biodistribution, bioavailability, local concentration, and clearance of drug substances for the treatment of human disease, most notably cancer. Written by a team of international experts, this book examines the use of quantitative imaging techniques in designing and evaluating novel drug delivery systems and applications. Drug Delivery Applications of Noninvasive Imaging offers a full arsenal of tested and proven methods, practices and guidance, enabling readers to overcome the many challenges in creating successful new drug delivery systems. The book begins with an introduction to molecular imaging. Next, it covers: In vivo imaging techniques and quantitative analysis Table of Contents Preface ix contributors xi 1 Introduction to Molecular Imaging 1 Vikas Kundra 2 PET/SPECT: Instrumentation and Imaging Techniques 12 Yuan-Chuan Tai 3 Photoacoustic Tomography and Its Applications in Drug Delivery and Photothermal Therapy 45 Liang Song and Lihong V. Wang 4 Raman Microspectral Imaging for Label-Free Detection of Nanoparticle-Mediated Cellular and Subcellular Drug Delivery 70 Tatyana Chernenko, Lara Milane, Christian Matthäus, Max Diem, and Mansoor Amiji 5 A natomical and Functional MRI91 Edward F. Jackson 6 Quantitative Imaging in Drug Delivery 125 Kooresh I. Shoghi 7 PET Imaging of the Pharmacokinetics of Small Molecular-Weight Drugs 147 Stephen M. Moerlein and Zhude Tu 8 Imaging Peptides, Proteins, and Antibody Delivery 192 Frederik L. Giesel and Clemens Kratochwil 9 In Vivo Imaging and Delivery of siRNA199 Zdravka Medarova and Anna Moore 10 Imaging Cell Therapy 223 Yajie Liang and Jeff W. M. Bulte 11 Radiolabeled Liposomes as Drug Delivery Nanotheranostics 252 William T. Phillips, Ande Bao, Keitaro Sou, Shihong Li, and Beth Goins 12 Polymeric Micelles as Imaging Agents and Drug Delivery Systems 268 Jun Zhao and Chun Li 13 Perfluorocarbon Nanoparticles: Translating Bench Opportunities to the Clinic 296 G. M. Lanza, P. M. Winter, S. D. Caruthers, A. H. Schmieder, and S. A. Wickline 14 Cancer Theranostics with Hollow Gold Nanospheres 308 Wei Lu and Chun Li 15 Imaging Pulmonary Drug Delivery 333 Stephen P. Newman 16 In Vivo Imaging for Validation of Oral Dose Performance 367 Fiona J. McInnes and Howard N. E. Stevens 17 Role of Large Animal Models in Translational Studies of Imaging and Targeted Drug Delivery 389 Rajesh K. Uthamanthil and Mei Tian 18 Imaging Transcatheter Delivery to Liver Tumors 412 Adil Al-Nahhas, Meeran Naji, and Imene Zerizer 19 Direct Visualization of Therapeutic Radionuclide Distribution Using Nuclear Medicine Imaging: I-131 in Metastatic Thyroid Carcinoma 426 Ho Young Lee, June-Key Chung, So Won Oh, Jong Jin Lee, Keon Wook Kang, Do Joon Park, Bo Youn Cho, and Myung Chul Lee 20 Imaging Drug Delivery to the CNS Using Translational Positron Emission Tomography Studies 432 Chi-Ming Lee, Katarina Varnäs, and Lars Farde Index 449

    2 in stock

    £137.66

  • TransfusionFree Medicine and Surgery

    John Wiley and Sons Ltd TransfusionFree Medicine and Surgery

    1 in stock

    Book SynopsisThis book aims to be a guide to the practice of blood conservation. The first chapter discusses the legal and administrative aspects of bloodless medicine describing the legal principles and practical issues relatd to refusal of transfusion. The second is on balancing the risks and benefits of transfusion includes clinical vignettes of appropriate and inappropriate transfusion. The remainder of the book covers the principles and practice of bloodless medicine, including a chapter on the scientific issues of haemostasis and the investigation of bleeding idsorders. The book concludes with chapters on blood conservation in neonatal and paediatric surgery, the costs associated with blood transfusion and the quest for artifical blood. New chapters will be included to address blood utilization in oncology and geriatric patients.Table of ContentsContributors, ix Preface, xiii 1 History of blood transfusion and patient blood management, 1 Shannon L. Farmer, James Isbister, and Michael F. Leahy 2 The ethical complexities of transfusion-free medicine, surgery and research, 19 Katrina A. Bramstedt 3 Transfusion therapy – Balancing the risks and benefits, 28 Irina Maramica and Ira A. Shulman 4 The physiology of anemia and the threshold for blood transfusion, 61 Senthil G. Krishna, Ahsan Syed, Jason Bryant, and Joseph D. Tobias 5 Blood transfusion in surgery, 83 Sharad Sharma, Lance W Griffin, and Nicolas Jabbour 6 Current view of coagulation system, 102 Yoogoo Kang and Elia Elia 7 Topical hemostatic agents, 143 Fabrizio Di Benedetto and Giuseppe Tarantino 8 Intraoperative strategies for transfusion-free medicine, 158 Joseph D. Tobias 9 Post-operative management in transfusion-free medicine and surgery in the ICU, 207 Jean-Louis Vincent 10 The changing transfusion practice of neonatal and pediatric surgery, 222 Pamela J. Kling and Nicolas Jabbour 11 Current management of anemia in oncology, 247 Shelly Sharma and Sharad Sharma 12 Artificial blood, 271 Aryeh Shander, Mazyar Javidroozi, and Seth Perelman 13 Translational strategies to minimize transfusion requirement in liver surgery and transplantation: Targeting ischemia-reperfusion injury, 289 Reza F. Saidi and S. Kamran Hejazi Kenari 14 Legal and administrative issues related to transfusion-free medicine and surgery programs, 315 Randy Henderson and Nicolas Jabbour 15 Basic principles of bloodless medicine and surgery, 338 Nicolas Jabbour Index, 347

    1 in stock

    £65.66

  • John Wiley & Sons Inc Medical Dosage Calculations For Dummies

    Out of stock

    Book SynopsisScore your highest in a medical dosage calculations course A recent shortage of nurses in a society with an aging population has triggered the demand for students to enter the field of medical study.Table of ContentsIntroduction 1 Part I: Getting Up to Speed: Reviewing Math Basics 7 Chapter 1: Brushing Up on Your Math Skills and Entering the Healthcare Field 9 Chapter 2: Using Numbers and Arithmetic 21 Chapter 3: Getting Familiar with Fractions and Their Fanatic Forms 37 Chapter 4: Getting Familiar with Systems of Measurement and Unit Conversions 53 Part II: Minding Your Meds: Administration and Calculation Methods 73 Chapter 5: The Prescription: Just What the Doctor Ordered 75 Chapter 6: Medication Labels and atient Safety 95 Chapter 7: Proper Medical Documentation and Dispensation 111 Chapter 8: Mastering Calculation Methods for Dosing Meds 123 Part III: Calculations for Different Routes of Administration 141 Chapter 9: Oral Calculations: Tablets, Capsules, and Liquids 143 Chapter 10: Parenteral Injections and Calculations 165 Chapter 11: The IV League: Intravenous Dosing and Calculations 181 Chapter 12: Working with Reconstituted Solutions: It’s like Magic 203 Part IV: Dosing in Special Situations 215 Chapter 13: Insulin: Call It a Miracle Drug 217 Chapter 14: Dosing for Two: The Pregnant Patient 231 Chapter 15: Kid Stuff: Pediatric Calculations 247 Chapter 16: Adjusting Dosages for People in Special Situations 269 Chapter 17: Critical Care Dosing and Calculations 285 Chapter 18: Keeping a Patient Well-Nourished 315 Part V: The Part of Tens 329 Chapter 19: Ten Essential Dosing Calculations 331 Chapter 20: Ten Ways to Avoid Common Dosing Mistakes 339 Index 347

    Out of stock

    £20.89

  • Pharmaceutical Emulsions

    John Wiley and Sons Ltd Pharmaceutical Emulsions

    1 in stock

    Book SynopsisPharmaceutical Emulsions: A Drug Developer's Toolbag covers all the key aspects of pharmaceutical emulsions, starting from the fundamental scientific basics, to the pharmaceutical forms and the chemical tests for its application.Table of ContentsMathematical symbols (with normal units) xi Acronyms and abbreviations xiii Preface xv Acknowledgements xvii About the companion website xix I Product considerations: medicinal formulations 1 1 Historical perspective 5 1.1 Landmarks 5 1.2 Significant discoveries 7 1.3 Difficulties 8 1.4 Traditional uses 10 1.5 Product regulation 13 2 What is an emulsion? 15 2.1 States of matter 24 2.2 Summary thermodynamics 34 2.3 Interfacial tension and wetting 36 2.4 Shear and size reduction 46 2.5 Raw materials 47 3 Stability, metastability and instability 49 3.1 Stokes’ law 51 3.2 Derjaguin–Landau–Verwey–Overbeek (DLVO) theory 52 3.3 Interfacial rheology 56 4 Manufacture 63 4.1 Premixing 63 4.2 High-shear mixers and size reduction 64 4.3 Multiple and microemulsions 65 4.4 Hot melt (steriles) 65 4.5 Filling 66 II Forms, uses and applications: biopharmaceutics 67 5 Creams and ointments 69 5.1 Nutraceuticals and cosmeceuticals 71 5.2 Medicinals 71 6 Pastes and bases 77 6.1 Emolliency 77 6.2 Suppositories 78 6.3 Pessaries 79 7 IV colloids 81 7.1 Needle free 86 7.2 Ocular therapy 87 7.3 Cancer 88 7.4 Antimicrobials 90 7.5 Temperature-sensitive matrices and release forms 93 7.6 Targeted endosomal use 94 7.7 Solid lipid nanoparticles 95 7.8 Diagnostic emulsions 98 8 Transdermal patches: semisolids 99 8.1 Hormones 104 8.2 Analgesia 104 8.3 Anaesthesia 104 8.4 Nicotine 105 8.5 Inserts: vaginal rings 105 9 Gels 107 9.1 Micro- and nanogels 107 9.2 Semisolids 107 10 Implants 109 10.1 Plastics and glasses 109 10.2 Thermoresponsive materials 110 11 De novo science, sustainable novel products and platform applications 111 11.1 Tablets 113 11.2 Metered-dose inhalers 113 11.3 Blood substitutes 114 III Tests: chemistry to control the quality, efficacy and fitness for purpose of a product 117 12 Physicochemical properties 119 12.1 Thermal evaluation (differential scanning calorimetry) and lipid polymorphs 124 12.2 Drug form, log P and Lipinski rules 129 12.3 Skin and epithelial models 133 12.4 Drug delivery routes 134 13 Sizing and microscopy 137 13.1 ζ -potential 137 13.2 Hydrodynamic diameter 139 14 Rheology, texture, consistency and spreadability 141 14.1 Bulk properties 141 14.2 Solid-state and nanorheological properties 144 14.3 Interfacial properties 144 15 Quality control, process analytical technology and accelerated testing 149 15.1 Preformulation, high-throughput screening 150 15.2 Industrial concerns 151 15.3 Rancimat and other methods 152 Questions 155 Guide for readers 155 Specimen 'test' questions 155 Answers 168 References 173 Index 181

    1 in stock

    £56.00

  • The Impact of Stereochemistry on Drug Development

    John Wiley & Sons Inc The Impact of Stereochemistry on Drug Development

    10 in stock

    Book SynopsisProvides an authoritative source of practical information on stereochemistry and its impact on drug development. Unlike other books which focus on synthesis, this work explores analytical, pharmacological, and regulatory topics in dealing with the theory and practice of stereochemistry in the pharmaceutical industry today. It specifically addresses how the body metabolizes chiral molecules; the varying effects of different chiral molecules; and provides detailed evaluations of current seperation techniques. Includes regulatory information.Table of ContentsPartial table of contents: Chirality and Drug Hazards (H. Aboul-Enein & L. Basha). Stereochemical Aspects of Drug Metabolism (J. Mason & A. Hutt). Some Examples for Stereoselective Biotransformation of Drugs (G. Blaschke). Chiral Barbiturates: Synthesis, Chromatographic Resolutions, and Biological Activity (J. Bojarski). Stereogenic Elements of Pharmaceutical Compounds: Some Aspects on Isomerism, Resolution, and Stereochemical Integrity (S. Allenmark). The Importance of Chiral Separations in Pharmaceuticals (S. Ahuja). Micelle-Mediated Capillary Electrophoretic Separation of Enantiomeric Compounds (M. Swartz & P. Brown). Chiral Derivatization Reagents in the Bioanalysis of Optically Active Drugs with Chromophore-Based Detection (R. Büschges, et al.). Circular Dichroism in the Study of Stereoselective Binding of Drugs to Serum Proteins (C. Bertucci, et al.).

    10 in stock

    £208.95

  • Medical Botany Plants Affecting Human Health

    John Wiley & Sons Inc Medical Botany Plants Affecting Human Health

    4 in stock

    Book SynopsisOrganized by body system and ailment makes it easy to locate appropriate therapies. Includes background on the physiology of major systems and ailments so readers can understand how and why a pharmaceutical, botanical, or dietary supplement works. Broad coverage includes green plants, fungi, and microorganisms.Trade Review"...an extremely good read...a productive mine of information...laced liberally with humour, human observation and practical examples..." (Plant Talk, May 2004)Table of ContentsProprietary Registered and Trademark Names and Owners. Preface. Acknowledgements. 1. Introduction. 2. Complementary and Alternative Medicine. PART I: INJURIOUS PLANTS. 3. Internal Poisons. 4. Immune System and Cell Modifiers. 5. Allergies. PART II: REMEDIAL PLANTS. 6. Cancer. 7. Musculoskeletal System. 8. Peripheral Nervous System. 9. Heart and Circulation. 10. Metabolism. 11. Sensory Organs: Eye and Ear. 12. Oral Hygiene. 13. Gastrointestinal Tract. 14. Respiratory System. 15. Urogenital System. 16. Skin. 17. Deterrents: Antibiotics, Antiseptics, Pesticides, and Herbicides. 18. Panaceas, Adaptogens, and Tonics. PART III: PSYCHOACTIVE PLANTS. 19. Central Nervous System and Psychiatry. 20. Stimulants. 21. Hallucinogens. 22. Depressants. Appendix A: Outline Classification of Plants. Appendix B: Bibliography of Traditional and Herbal Medicine and Ethnobotany. Glossary. Index.

    4 in stock

    £118.76

  • Ben Cao Gang Mu Volume I Part A

    University of California Press Ben Cao Gang Mu Volume I Part A

    1 in stock

    Book SynopsisVolume I is divided into two parts. Part A of volume 1 in theBen cao gang museries offers a translation of chapters 1 and 2 and portions of chapter 3. Chapters 1 and 2 are devoted to introducing the history of materia medica. Chapter 3 is devoted to pharmaceutical drugs for diseases. Chapter 3 is continued, along with chapter 4, in part B of volume I. TheBen cao gang muis a sixteenth-century Chinese encyclopedia of medical matter and natural history by Li Shizhen (15181593). The culmination of a sixteen-hundred-year history of Chinese medical and pharmaceutical literature, it is considered the most important and comprehensive book ever written in the history of Chinese medicine and remains an invaluable resource for researchers and practitioners. This nine-volume series reveals an almost two-millennia-long panorama of wide-ranging observations and sophisticated interpretations, ingenious manipulations, and practical applications of natural substances for the benefit of human health. Paul U. Unschuld's annotated translation of theBen cao gang mu, presented here with the original Chinese text, opens a rare window into viewing the people and culture of China's past.Table of ContentsContents 1. Prolegomena. 1.1 History of Chinese materia medica literature. 1.2 Structure and contents of the Ben cao gang mu. 1.3 Biographical sketch of Li Shizhen (1518 – 1593). 2. Notes on the translation. 3. Wang Shizhen’s preface of 1590 4. Detailed survey of contents chapters 1 through 4 5. (Original) Complete Contents, ch. 1 through 52 6. Translation of the Ben cao gang mu, chapters 1 through 3-49

    1 in stock

    £127.20

  • Ben Cao Gang Mu Volume I Part B

    University of California Press Ben Cao Gang Mu Volume I Part B

    3 in stock

    Book SynopsisVolume I is divided into two parts. Part B of volume I in theBen cao gang museries offers a translation of portions of chapter 3 and the complete chapter 4, devoted to pharmaceutical drugs for diseases. This volume is a continuation of volume I, part A. The first portion of chapter 3 is found in part A. TheBen cao gang muis a sixteenth-century Chinese encyclopedia of medical matter and natural history by Li Shizhen (15181593). The culmination of a sixteen-hundred-year history of Chinese medical and pharmaceutical literature, it is considered the most important and comprehensive book ever written in the history of Chinese medicine and remains an invaluable resource for researchers and practitioners. This nine-volume series reveals an almost two-millennia-long panorama of wide-ranging observations and sophisticated interpretations, ingenious manipulations, and practical applications of natural substances for the benefit of human health. Paul U. Unschuld's annotated translation of theBen cao gang mu, presented here with the original Chinese text, opens a rare window into viewing the people and culture of China's past.

    3 in stock

    £127.20

  • Case Studies Stahls Essential Psychopharmacology

    Cambridge University Press Case Studies Stahls Essential Psychopharmacology

    15 in stock

    Book SynopsisCapitalizing on Dr Stahl's greatest strength - the ability to address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians - this book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey.Trade Review'The case studies accurately reflect the complicated nature of the patients that we encounter in our practices … This novel book helps us look inside the mind of a seasoned psychopharmacologist and how he bridges the gap between research and clinical practice.' Doody's NotesTable of Contents1. The man whose antidepressants stopped working; 2. The son who would not take a shower; 3. The man who kept hitting his wife over the head with a frying pan; 4. The son who could not go to bed; 5. The sleepy woman with anxiety; 6. The woman who felt numb; 7. The case of physician do not heal thyself; 8. The son whose parents were desperate to have him avoid Kraepelin; 9. The soldier who thinks he is a 'slacker' broken beyond all repair after 3 deployments to Iraq; 10. The young man everybody was afraid to treat; 11. The young woman whose doctors could not decide whether she has schizophrenia, bipolar disorder or both; 12. The scary man with only partial symptom control on clozapine; 13. The 8-year-old girl who was naughty; 14. The scatter-brained mother whose daughter has ADHD, like mother, like daughter; 15. The doctor who couldn't keep up with his patients; 16. The computer analyst who thought the government would choke him to death; 17. The severely depressed man with a life insurance policy soon to lose its suicide exemption; 18. The anxious woman who was more afraid of her anxiety medications than of anything else; 19. The psychotic woman with delusions that no medication could fix; 20. The breast cancer survivor who couldn't remember how to cook; 21. The woman who has always been out of control; 22. The young man with depression and alcohol abuse - like father, like son, like grandfather, like father, like great grandfather, like grandfather; 23. The woman with psychotic depression responsive to her own TMS machine; 24. The boy getting kicked out of his classroom; 25. The young man whose dyskinesia was prompt and not tardive; 26. The patient whose daughter wouldn't give up; 27. The psychotic arsonist who burned his house and tried to burn himself; 28. The woman with depression whose Parkinson's Disease vanished; 29. The depressed man who thought he was out of options; 30. The woman who was either manic or fat; 31. The girl who couldn't find a doctor; 32. The man who wondered if once a bipolar always a bipolar?; 33. Suck it up, soldier, and quit whining; 34. The young man who is failing to launch; 35. The young cancer survivor with panic; 36. The man whose antipsychotic almost killed him; 37. The painful man who soaked up his opiates like a sponge; 38. The woman with an ever fluctuating mood; 39. The psychotic sex offender with grandiosity and mania; 40. The elderly man with schizophrenia and Alzheimer's Disease; Index.

    15 in stock

    £60.99

  • Ashgate Handbook of Endocrine Agents and Steroids

    John Wiley & Sons Inc Ashgate Handbook of Endocrine Agents and Steroids

    Out of stock

    Book SynopsisTreatment of endocrine disorders is an important branch of medicine and many drugs have been developed for use in this area. Endocrine disorders and the drugs used to treat them are quite diverse, ranging from iodine-containing thyroxine analogs used to treat hypothyroidism, to steroid androgens, progestins and estrogens.Table of ContentsPreface. Acknowledgements. How to Use This Book. Glossary of Units. Abbreviations. Part I: Main Entries. Pituitary/Hypothalamic Agents. Adrenocortical Agents. Androgens and Anabolic Steroids. Calcium Metabolizing Agents. Estrogens and Progestins. Glucose Regulating Agents. Thyroids and Antithyroids. Steroids, General. Part II: Indexes. CAS Registry Number Index. EINECS Number Index. Name and Synonym Index. Part III: Manufacturers and Suppliers Directory.

    Out of stock

    £204.26

  • Harvard University Press New Plant Sources for Drugs and Foods from the

    Out of stock

    Book SynopsisThis companion volume to Siri von Reis's previous exploration of ethnobotanical notes in the Harvard herbaria brings to light a new array of plants with drug or food potential, offering wide-ranging possible applications for pharmacologists, chemists, botanists, and even anthropologists.Table of ContentsIntroduction Catalogue Entries Index to Families Index to Genera Index to Common Names Index to Uses

    Out of stock

    £37.36

  • Elsevier Health Sciences The Unofficial Guide to Prescribing

    Out of stock

    Book SynopsisLays out the practical steps of how to assess, investigate and manage a patient, with a focus on what to prescribe and how to prescribe it. This title aims to empower newly graduated junior doctors to excel at dealing with emergencies and handling complex prescribing scenarios.Trade Review"As part of 'The Unofficial Guide to.' series, this excellent book is a must have for all students, as well as professionals involved in prescribing and hospital care - it provides a solid foundation for dealing with emergency situations and complex prescribing scenarios. It strengthens theoretical knowledge and applies it to 'real life' situations...it is an essential resource that should hold a place on all university reading lists".Reviewed by: Dr Irfan Rashid on behalf of the International Journal of Clinical Skills, Jan 2015Table of Contents1 Introduction to prescribing. 2 Cardiology. 3 Respiratory medicine. 4 Gastroenterology. 5 Neurology. 6 Endocrinology. 7 Obstetrics and gynaecology. 8 General surgery. 9 Paediatrics. 10 Additional important scenarios.

    Out of stock

    £28.49

  • Elsevier Health Sciences Clinical Pharmacy and Therapeutics

    Out of stock

    Book SynopsisTrade ReviewFrom reviews of the previous edition: 'Brill book for any undergraduate pharmacy student; covers the major therapeutic areas with nice little case studies with answers at the end of each chapter to get you thinking. Additionally, the first few chapters cover generic topics such as biochemical tests with plenty of detail and references. Highly recommend.' 'A highly informative essential for any pharmacy student. Through my four years of pharmacy education, this book was second only to the BNF in sheer frequency of use.' 'An excellent book for the pharmacist undertaking a clinical diploma. Clear and very informative.' 'Excellent book to gain an overall well rounded knowledge of the subject. As much as you need to know as a pharmacy student and pharmacist, if not more. Excellent revision tool for making notes.' 'If you are about to undertake Non-Medical Prescribing then this is probably the only book you'll need to buy.' 'Very good book with a good depth of knowledge which is useful for clinical pharmacists, doctors and other healthcare professionals.' 'This new edition was really very helpful when I was doing an MSc course in Advanced Pharmacy Practice and it was really very helpful in all the clinical diseases I have to read for my PBL. I also used it as one of my most reliable reference books for the in-course simulation ward rounds and other clinical case studies.' 'It is a great book to have as a practising Clinical or Hospital pharmacist or even Community Pharmacist. It will also be of great use to anyone doing a course in pharmacotherapy. This book will always be of use to you throughout your studentship or when practising after graduation. It is also more portable than most other pharmacotherapy textbooks with the same amount of information.'Table of ContentsSection 1: General Clinical pharmacy process Prescribing Practical pharmacokinetics Drug interactions Adverse drug reactions Laboratory data Parenteral nutrition Pharmacoeconomics Section 2: Life stages Neonates Paediatrics Geriatrics Section 3: TherapeuticsGastrointestinal disorders Peptic ulcer disease Inflammatory bowel disease Constipation and diarrhoea Adverse effects of drugs on the liver Liver disease. Acute kidney injury Chronic kidney disease and end-stage renal disease Hypertension Coronary heart disease Chronic heart failure Arrhythmias Thrombosis Dyslipidaemia Asthma Chronic obstructive pulmonary disease Insomnia Anxiety disorders Affective disorders Schizophrenia Epilepsy Parkinson's disease Dementia Pain Nausea and vomiting Respiratory infections Urinary tract infections Gastrointestinal infections Infective meningitis Surgical site infection and antimicrobial prophylaxis Tuberculosis HIV infection. Fungal infections Thyroid and parathyroid disorders Diabetes mellitus Menstrual cycle disorders Menopause Drugs in pregnancy and lactation Prostate disease. Anaemia. Leukaemia Lymphomas Solid tumours. Rheumatoid arthritis and osteoarthritis Gout and hyperuricaemia Glaucoma Drug-induced skin disorders Eczema and psoriasis Wounds. Section 4: Appendices. Medical abbreviations Glossary Index

    Out of stock

    £73.24

  • Elsevier Health Sciences Crash Course Pharmacology

    Out of stock

    Book SynopsisTable of ContentsChapter 1. Introduction to pharmacology Chapter 2. Peripheral nervous system Chapter 3. Respiratory system Chapter 4. Cardiovascular system Chapter 5. Kidney and urinary system Chapter 6. Gastrointestinal system Chapter 7. Endocrine and reproductive systems Chapter 8. Central nervous system Chapter 9. Drugs of abuse Chapter 10. Pain and anaesthesia Chapter 11. Inflammation, allergic diseases and immunosuppression Chapter 12. Infectious diseases Chapter 13. Cancer

    Out of stock

    £999.99

  • Calculations and Pharmaceutics in Practice

    Elsevier Health Sciences Calculations and Pharmaceutics in Practice

    Out of stock

    Book SynopsisTable of ContentsUsing calculations in pharmacy practice Dispensing techniques (compounding and good practice) Oral unit dosage forms Packaging Solutions Suspensions Emulsions External preparations Suppositories and pessaries Powders and granules Sterile products Parenteral products Opthalmic products Inhaled products Parenteral nutrition and dialysis Radiopharmacy Specialized services Appliances Routes of administration and dosage forms

    Out of stock

    £999.99

  • Drug Discovery and Development

    Elsevier Health Sciences Drug Discovery and Development

    1 in stock

    Book SynopsisTable of ContentsSection 1 Introduction and Background 1. Development of the pharmaceutical industry 2. Nature of disease and purpose of therapy 3. Therapeutic modalities Section 2 Drug Discovery 4. Drug target identification 5. Selecting the modality and planning the project 6. High throughput screening 7. Medicinal Chemistry 8. Biopharmaceuticals and related molecules 9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process 10. Metabolism and Pharmacokinetical strategies. 11. Role of pharmacology to include pharmacology of newer modalities 12. In vitro in vivo translation 13. Vaccines Section 3 Drug Development 14. Drug development introduction 15. Drug safety 16. Pharmaceutical development 17. Clinical development 18. Clinical imaging 19. Intellectual property 20. Regulatory affairs 21. Marketing and Patient access to medicines Section 4 Facts and Figures 22. Facts and Figures; and the Future

    1 in stock

    £47.49

  • Human Kinetics Publishers Practical Pharmacology in Rehabilitation Effect

    Out of stock

    Book SynopsisPractical Pharmacology in Rehabilitation discusses the effects of medications in the rehabilitation process and assists rehabilitation professionals in designing patient-specific therapy plans based on coexisting disease states and medications used. Table of ContentsPart I: FoundationsChapter 1. Introduction to Medication Monitoring by the Rehabilitation Therapist Principles of Pharmacotherapy Generic Medications Side Effects of Medications Special Populations and Medication Risk Patient Education and Medication Use Safe and Effective Use of Medications Summary Chapter 2. Medication’s Effects on the Nervous System, Muscle Function, and Cognition Central Nervous System Peripheral Nervous System Medication-Induced Movement Disorders Summary Chapter 3. Nutrition in the Rehabilitation Patient Physiology of Nutrition Incidence, Etiology, and Pathophysiology of Malnutrition Nutritional Screening, Assessment, and Monitoring Rehabilitation Considerations Summary Part II: Medications Used to Treat Psychiatric and Cognitive DisordersChapter 4. Medications Used to Treat Depression and Bipolar Disorder Depression Drug Interactions With Antidepressants Bipolar Disorder Summary Chapter 5. Medications Used to Treat Psychosis and Schizophrenia Psychosis Agitation Side Effects Associated With Antipsychotic Agents Drug Interactions Role of the Rehabilitation Therapist in Promoting Medication Adherence Rehabilitation Considerations Summary Chapter 6. Medications Used to Treat Delirium, Dementia, and Alzheimer’s Disease Reversible Cognitive Impairment Caused by Medications Reversible Cognitive Impairment Caused by Medication-Associated Delirium Irreversible Cognitive Impairment Summary Chapter 7. Medications Used to Treat Anxiety, Anxiety Disorders, and Insomnia Anxiety Disorders Insomnia Summary Part III: Medications Used to Treat Neurologic and Movement DisordersChapter 8. Medications Used to Treat Seizure Disorders Classification of Seizures Seizures, Convulsions, and Epilepsy Summary Chapter 9. Medications Used to Treat Spasticity and Muscle Spasm Spasticity Muscle Spasm Summary Chapter 10. Medications Used to Treat Parkinson’s Disease Parkinson’s Disease Summary Chapter 11. Medications Used to Treat Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Myasthenia Gravis Amyotrophic Lateral Sclerosis Multiple Sclerosis Myasthenia Gravis Summary Chapter 12. Medications Used to Treat Other Movement Disorders Essential Tremor Subcortical Dementia Huntington’s Disease Wilson’s Disease Restless-Leg Syndrome Medication-Induced Movement Disorders Summary Part IV: Medications Used to Treat Pain and Substance-Use DisordersChapter 13. Medications Used to Treat Pain Classification of Pain Summary Chapter 14. Medications Used to Treat Chronic Pain Syndromes Migraine Headache Fibromyalgia Trigeminal Neuralgia Cancer Pain Amputation Pain Central Pain Syndromes Complex Regional Pain Syndrome Summary Chapter 15. Medications Used to Treat Substance-Use Disorders Definition of Substance-Use Disorder Alcohol-Abuse Disorders Drug-Abuse Disorders Summary Part V: Medications Used to Treat Disorders of the Immune SystemChapter 16. Medications Used to Treat Infections Classification of Bacteria Urinary Tract Infections Skin and Soft-Tissue Infections Surgical Wound Infections Vascular Ulcers and Pressure Ulcers Diabetic Foot Infections Pneumonia Antibiotic-Associated Diarrhea Control of Infection in the Rehabilitation Center Summary Chapter 17. Medications Used to Treat Osteoarthritis, Gout, and Rheumatoid Arthritis Osteoarthritis Gout Rheumatoid Arthritis Related Rheumatic Diseases Summary Chapter 18. Medications Used to Treat Cancer Definition of Cancer Summary Part VI: Medications Used to Treat Chronic DiseaseChapter 19. Medications Used to Treat Hypertension, Congestive Heart Failure, and Cardiac Arrhythmias Cardiovascular Disease Hypertension Congestive Heart Failure Cardiac Arrhythmias Summary Chapter 20. Medications Used to Treat Peripheral Artery Disease, Stroke, and Coronary Heart Disease Atherosclerosis Peripheral Artery Disease Stroke Coronary Artery Disease Summary Chapter 21. Medications Used to Treat Diabetes Diabetes Mellitus Diabetic Neuropathy Summary Chapter 22. Medications Used to Treat Respiratory Disease Respiratory System Chronic Obstructive Pulmonary Disease Emphysema Chronic Bronchitis Asthma Rehabilitation Considerations for Respiratory Disease Medication Therapy for Respiratory Disease Summary Chapter 23. Medications Used to Treat Thyroid Disease, Parathyroid Disease, and Osteoporosis Thyroid Disease Hyperthyroidism Hypothyroidism Osteoporosis Paget’s Disease Hyperparathyroidism Hypoparathyroidism Summary Chapter 24. Medications Used to Treat Gastrointestinal Disorders Nausea and Vomiting Constipation Irritable Bowel Syndrome Inflammatory Bowel Disease Dyspepsia and Disorders Associated With Delayed Gastric Emptying Eosinophilic Esophagitis Dysphagia Rehabilitation Considerations in Medication Review and Patient Education Summary

    Out of stock

    £72.90

  • Ibuprofen A Critical Bibliographic Review Taylor

    Taylor & Francis Ltd Ibuprofen A Critical Bibliographic Review Taylor

    15 in stock

    Book SynopsisIbuprofen is widely used throughout the world for a variety of conditions. This reference work provides a comprehensive and critical review of the basic science and clinical aspects of the drug. The book begins with the history and development of the drug and its current patterns of use world- wide before moving on to examine its basic pharmaceutical attributes and medicinal chemistry. The properties of various formulations are described (oral prescription and OTC, topical and others) are described. The pharmacokinetics of ibuprofen in animals and humans is discussed - highlighting the factors affecting absorption, distribution, metabolism and elimination. The clinical pharmacology and toxicology and the drug's mechanisms of action in different disease states and conditions are covered. The therapeutic uses in various acute and inflammatory conditions is detailed. Also considered are the safety versus efficacy issues and the pharmacoepidemiological data.Table of Contents1. History and Development of Ibuprofen K.D. Rainsford 2. The Medicinal Chemistry of Ibuprofen K.J. Nichol 3. The Pharmaceutics of Ibuprofen F. Higton 4. The Pharmacokinetcs of Ibuprofen in Humans and Animals D.R. Brocks and F. Jamaili 5. Pharmacology and Toxicology of Ibuprofen K.D. Rainsford 6. Therapeutics of Ibuprofen in Rheumatic and Other Chronic and Painful Diseases W.F. Kean, W.W. Buchanan and K.D. Rainsford 7. Safety and Efficacy of Non-Prescription (OTC) Ibuprofen K.D. Rainsford 8. Use of Ibuprofen in Dentistry R.A. Dionne and S.A. Cooper 9. Gastrointestinal Adverse Drug Reactions Attributed to Ibuprofen D.A. Henry, A. Drew and S. Beuzeville 10. Renal Effects of Ibuprofen M.D. Murray and D.C. Brater 11. Adverse Drug Reactions Attributed to Ibuprofen: Effects Other Than Gastrointestinal L.J. Miwa and J.K. Jones 12. Human Toxicity of Ibuprofen G.N. Volans and R. Fitzpatrick Nichol, Boots Pharmaceuticals, UK, F. Higton, Boots Healthcare International, D.R. Brock, Western University of Health Sciences, USA, F. Jamaili, University of Alberta, USA, W.F. Kean, McMaster University, Canada, W.W. Buchanan, Sir William Osler Health Institute, Canada, R.A. Dionne, National Istitute of Health, USA, S.A. Cooper, Whitehall-Robins Health Care, USA, D.A. Henry, Newcastle Mater Hospital, Australia, A. Drew, Newcastle Mater Hospital, Australia, S. Beuzeville, Newcastle Mater Hospital, Australia, M.D. Murray, Regenstrief Health Centre, USA, D.C. Brater, Indiana university School of Medicine, USA, L.J. Miwa, The Degge Group, USA, J.K. Jones, The Degge Group, USA, G.N. Volans, Guys and St. Thomas' Hospital Trust, UK, R. Fitzpatrick, Guys and St. Thomas' Hospital Trust, UK.

    15 in stock

    £453.63

  • Aspirin and Related Drugs

    Taylor & Francis Ltd Aspirin and Related Drugs

    1 in stock

    Book SynopsisReviewing over a century of aspirin research and use, Aspirin and Related Drugs provides a comprehensive source of information on the history, chemistry, absorption in the body, therapeutic effects, toxicology, elimination, and future uses of aspirin.Highlighting the historical evolution of the salicylates and the commercial development of aspirin, the book reviews the pharmacokinetics of the salicylates, ibuprofen, and paracetamol as a basis for understanding the biodisposition of these analgesic drugs. Leading specialists discuss the therapeutic role of aspirin in the prevention and treatment of thrombo-embolic diseases, its place along with non-acetylated salicylates in the treatment of rheumatic diseases and plain, and the potential applications for aspirin and related drugs as prophylactics for colon cancer, Alzheimer's disease, and vascular dementia. They also present comparisons with other drugs used to treat pain and inflammation.With extensive data and literTable of ContentsHistory and Development of the Salicylates. The Industrial History of Analgesics: The Evolution of Analgesics and Antipyretics. Occurrence, Properties and Synthetic Developments of the Salicylates. Pharmacokinetics and Metabolism of the Salicylates. Metabolism and Pharmacokinetics of Ibuprofen. Pharmacokinetics and Metabolism of Paracetamol (Acetaminophen). Pharmacology and Biochemistry of Salicylates and Related Drugs. Side-effects and Toxicology of the Salicylates. Reye's Syndrome and Aspirin. Salicylates in the Treatment of Acute Pain. Acetysalicylic Acid for the Prevention and Treatment of Thromboembolic Diseases. Use of Salicylates in Rheumatic and Related Conditions. Aspirin and NSAIDs in the Prevention of Cancer, Alzheimer's Disease and other Novel Therapeutic Actions.

    1 in stock

    £220.00

  • Interindividual Variability in Human Drug

    Taylor & Francis Ltd Interindividual Variability in Human Drug

    1 in stock

    Book SynopsisThe book provides an exhaustive, authoritative and updated review on the interindividual variability in drug metabolism in humans. Four chapters address the general background: genetic factors causing variability, interethnic variability, environmental factors and developing and ageing as sources of variability. Six chapters address variability of drug metabolism in vivo: variability of psychotropic drugs, antiepileptic drugs, the dopamine precursor levodopa, cardiovascular active drugs and anti HIV drugs. Seven chapters address the interindividual variability of the main drug metabolizing enzymes: CYP-450s, acetyltransferases, glucuronosyl transferase, methyl transferases, sulfotransferases and glutathione transferases in human liver and extrahepatic tissues. A separate chapter discusses the prediction of drug interaction.Comprehensive in coverage, and with contributions from the leading international experts, this book is essential reading for researchers from both academiTable of ContentsGenetic Factors That Cause Variability in Human Drug Metabolism. Interethnic Differences in Drug Disposition and Effects. Developing and Ageing as Sources of Variability in Drug Metabolism. Genetic and Environmental Factors Causing Variability in Psychotropic Drug Response. Interindividual Variability in the Metabolism of Cardiovascular Drugs. Interindividual Variability in the Metabolism of Antiepileptic Drugs and its Clinical Implications. Variability in the Metabolism of Levodopa and its Clinical Implications. Interindividual Variability in the Disposition of Anti-HIV Drugs. Predictive Modeling of in vivo Drug Interaction From in vitro Data: From Theory to a Computer-based Workbench and Experimental Validation. Interindividual Variation of P450 Enzymes in vitro and it's Causes. Interindividual Variability of Arylamine N-acetyltransferases. Interindividual Variation of UDP-glucuronosyl Transferases and Drug Glucuronidation. Interindividual Variability of Methyltransferases. Interindividual Variability of Sulpho Transferases. Interindividual Variability of Glutathione Transferase Expression

    1 in stock

    £237.50

  • Drug Therapy for Stroke Prevention

    Taylor & Francis Ltd Drug Therapy for Stroke Prevention

    1 in stock

    Book SynopsisStroke is the third leading cause of death in the USA and UK. It is a major cause of disability among adults and is a significant factor in dementia in later life and its incidence is on the rise. This book discusses specific medications that target the blood and vasculature and how these treatments can be used to complement other therapeutic measures, such as carotid endarterectomy. It covers the pharmacological methods used to address the risk factors in stroke, the major drug discoveries of recent years--antiaggregant, antithrombotic, and anticoagulant therapies--and also long established therapies such as aspirin and warfarin. With contributions by internationally recognized experts, this is a unique single source of information on current pharmacological prevention of stroke.Table of Contents1. Stroke Prevention in 2000 J. Easton 2. Primary vs. Secondary Stroke Prevention P. Gorelick 3. Aspirin P. De Moerloose 4. Ticlopidine and Clopidogrel M. Paciaroni 5. Other Anti-platelet Agents A. Culebras 6. Dipyridamole H. Diener 7. New Antiplatelet Agents B. Weksler 8. Clinical Use of Antiplatelet Agents for Stroke Prevention G. Donnan 9. Antithrombotic Therapy Before and After Carotid Endarterectomy H. Barnett 10. Anticoagulants T. Moulin 11. Early Prevention of Stroke Recurrence M. Brown 12. Lipid Lowering Agents and Stroke Risk P. Amarenco 13. Stroke Prevention With Blood Pressure Control P. Bath 14. Antioxidants, Vitamins D. Spence 15. Estrogen Replacement L. Brass 16. Healthcare Issues, Benefits and Costs G. Hankey Gorelick, Centre for Stroke Research, USA, Babette Weksler, Cornell University, USA, Geoffrey Donnan, National Stroke Research Institute, Australia, H. Barnett, Robarts Research Institute, Canada, Martin Brown, University of London, UK, Pierre Amarenco, Hospital Lariboisere, France, Phillipe Bath, Nottingham City Hospital, UK, J. David Spence, Robarts Research Institute, Canada, Graeme Hankey, Royal Perth Hospital, Australia, H. Diener, Neurologische Uniklinik, Germany, Lawrence Brass, Yale University School of Medicine, USA, Thierry Moulin, Hospital Regional de Bescancon, Maurizio Paciaroni, University of Perugia, Italy, Antonio Culebras, VA Medical Centre, USA, Phillipe de Moerloose, HUG, Geneva.

    1 in stock

    £115.00

  • Frankie The Woman Who Saved Millions from

    The History Press Ltd Frankie The Woman Who Saved Millions from

    5 in stock

    Book SynopsisThe story of the one woman who, against all odds, stopped Thalidomide in its tracks because it poisoned a nation

    5 in stock

    £15.29

  • Anesthetic Toxicity

    Taylor & Francis Ltd Anesthetic Toxicity

    Out of stock

    Book SynopsisThis text is a source of information on the toxicity of anaesthetic agents. The editors define toxicity in a broad sense to mean an adverse effect, whether that effect is the result of pharmacological, toxicological, physiological, or other mechanisms. They bring together reviews by experts in the disciplines concerned - including biochemistry, genetics, and immunology - involved in current research on these adverse effects.; The initial chapters provide an understanding of the factors responsible for toxicity, and the ways in which the adverse effects of anaesthetics can be investigated. Subsequent chapters cover topics such as: hepatotoxicity; nephrotoxicity; malignant hyperthermia triggered by anaesthetics; pulmonary effects of anaesthesia; toxicity of local anaesthetic agents; toxicity of nitrous oxide; immunosuppression in the postoperative period; and reproductive and developmental toxicity of anaesthetics. Many of the contributors offer insights into the anaesthetics and their iTable of ContentsAnaesthetic Toxicity: An Overview, Susan A. Rice and Kevin J. Fish Animal Use in Toxicity Evaluation , Victor S. Lukas, Jr. Principles of Epidemiology for Evaluation of Anaesthetic Toxicity, Kristie L. Ebi Metabolism of the Volatile Anaesthetics, Lucy Waskell Hepatotoxicity of Halogenated Anaesthetics, Max T. Baker and Russell van Dyke Nephrotoxicity of Volatile Anaesthetic Agents, Kevin J. Fish The Toxicity of Local Anaesthetic Agents, Hal S. Feldman Toxicity of Nitrous Oxide, Donald D. Koblin Reproductive and Developmental Toxicity of Anaesthetics in Animals, Susan A. Rice Reproductive and Developmental Toxicity of Anaesthetics in Humans, Kristie L. Ebie and Susan A. Rice Pharmacogenetics and Anaesthetic Toxicity, Margaret Wood Malignant Hyperthermia Triggered by Anaesthetics, Marilyn Green Larach Immunosuppression in the Postoperative Period, Girish C. Moudgil Pulmonary Effects of Anaesthesia, Brian P. Kavanagh and Ronald G. Pearl Biomarkers of Anaesthetic Toxicity, C. Murray Ardie.

    Out of stock

    £142.50

  • Johns Hopkins University Press Prescribing by Numbers

    Out of stock

    Book SynopsisRather, his provocative and comprehensive analysis sheds light on the increasing presence of the subjectively healthy but highly medicated individual in the American medical landscape, suggesting how historical analysis can help to address the problems inherent in the program of pharmaceutical prevention.Trade ReviewGreene provides suggestions on how to address some of the problems inherent in medical prevention. Choice 2007 Shows how the process of defining disease 'illustrates the porous relationship between the science and the marketing of health care.' -- Nina C. Ayub Chronicle of Higher Education 2007 A gripping story... Greene warns us in his superb book that things are not always as they are claimed. -- Howard Spiro Yale Journal for Humanities in Medicine 2007 This is, I believe, one of the best, and most significant, books published recently on the development of medical practice and the pharmaceutical industry in the USA in the second half of the twentieth century. -- Judy Slinn Social History of Medicine 2007 Greene focuses on the question of how public health priorities became closely aligned with the pharmaceutical industry's marketing practices... Offers a nuanced description of the development of 'therapeutics of risk reduction' with multiple lines of influence, subtle power shifts, and gains and losses for patients and physicians. -- Arthur Daemmrich Chemical Heritage 2008 Greene describes the relationship between advances in treatment, the incentives of manufacturers, and the effect on the public of increased attention to prevention... The risk-benefit trade-offs of the quantitative approach are complex, and Greene's historical revelations are timely. -- Kevin A. Schulman, M.D. New England Journal of Medicine 2007 The interaction between medical science and industry has been fruitfully explored by several excellent historians... but Greene's intricate narratives extend their work. -- Marcia Meldrum Isis 2008 I heartily recommend this book. -- Toine Pieters Medical History 2008 By the end of Prescribing by Numbers, one realizes it is an excellent book to think with. Greene uses his case studies to juxtapose the therapeutics of risk with more contemporary health dilemmas. -- Gregory J. Higby Pharmacy in History 2009 Greene's nuanced and lucid research yields new insight into the mechanisms that linked specific medications to the management of particular chronic diseases in the postwar era. -- Cynthia A. Connolly, PhD, RN Nursing History Review 2011Table of ContentsPrefaceAcknowledgmentsIntroduction: The Pharmacopoeia of Risk ReductionPart One: Diuril and Hypertension, 1957-19771. Releasing the Flood Waters: The Development and Promotion of Diuril2. Shrinking the Symptom, Growing the Disease: Hypertension after DiurilPart Two: Orinase and Diabetes, 1960-19803. Finding the Hidden Diabetic: Orinase Creates a New Market4. Risk and the Symptom: The Trials of OrinasePart Three: Mevacor and Cholesterol, 1970-20005. The Fall and Rise of a Risk Factor: Cholesterol and Its Remedies6. Know Your Number: Cholesterol and the Threshold of PathologyConclusion: The Therapeutic TransitionNotesIndex

    Out of stock

    £999.99

  • Palladium Assisted Synthesis of Heterocycles

    Taylor & Francis Inc Palladium Assisted Synthesis of Heterocycles

    5 in stock

    Book SynopsisThis book is a compilation of the recent applications of palladium catalysts in organic synthesis. The book demonstrates that it is a highly dynamic research field. This methodology has emerged as a powerful tool for the efficient and chemoselective synthesis of heterocyclic molecules. In the past few years, several strategies have been pointed out to pursue more efficient, sustainable, and environment friendly chemical processes. Among those strategies, catalysis and the design of new processes that avoid the use of toxic reagents have been the focus of intense research.Trade Review'The book “Palladium Assisted Synthesis of Heterocycles” presents a thorough compilation of modern palladium-catalysed synthetic methodologies aimed at accessing heterocycles of various nature and size. It is well-structured and written and covers literature extensively for the last two decades of research in the field. The book is highly recommended to all medicinal chemists who are interested in incorporating heterocycles into their lead molecules and are looking for a concise synthetic approach to making them. It is also recommended to all process chemists who are developing expedient and reliable methods aimed at accessing heterocyclic molecules.From my personal perspective, the book is clearly written, concise and easy to read.'— Fedor Romanov Michailidis, Johnson Matthey Technol. Rev., 2021, 65, (3), 496Table of ContentsPalladium catalyzed synthesis of heterocycles: An Introduction. Five-membered N-heterocycles. Five-membered N-polyheterocycles. Five-membered fused N-heterocycles. Five-membered N, N-heterocycles. Five-membered poly and fused O-heterocycles. Five-membered O,N-heterocycles. Six-membered N-heterocycles. Six-membered N-polyheterocycles. Six-membered fused N-heterocycles. Six-membered N, N-heterocycles. Seven-membered heterocycles.

    5 in stock

    £210.00

  • Duke University Press A Reference Guide to Medicinal Plants

    Out of stock

    Book SynopsisCovers over 700 medicinal plants, of which more than 150 are readily obtainable in health-food stores and other outlets. In this book, each account of a plant includes the herbalist's comment, an assessment of the plant's efficacy, and information on its chemical constituents and pharmacological affects.Trade ReviewoThe historical comments that follow BassOs opinions are truly excellent. Detailed nad well referenced, they are essential reading for all persons interested in the history of herbs and their use.ONVarro E. Tyler, Pharmacy in History oEasily the most important historical commentary on American medicinal plants in two decades.ONFosterOs Botanical and Herb Reviews oA veritable treasure-house of information that could be a baseline for future research on little-known herbals.ONB. Subramanian, Journal of Scientific and Industrial Research

    Out of stock

    £999.99

  • Environmental Stressors in Health and Disease

    Taylor & Francis Inc Environmental Stressors in Health and Disease

    1 in stock

    Book SynopsisThis volume illustrates the impact of environmental oxidants on the tissues of the eyes, lungs and skin, as well as on the immune system - highlighting common illnesses, injuries and pathologies induced by pro-oxidant environmental xenobiotics such as inflammation, immune response, signal transduction, regulation of gene expression, and carcinogenesis. It provides clinical presentations and discusses the effects of environmental oxidants on target organs.Table of ContentsMolecular and cellular aspects of pro-oxidant environmental xenobiotics: free radical reactions in human disease; radicals and inflammation - mediators and modulators; autoimmunology caused by oxidising foreign compounds; role of oxidative stress in chemical carcinogenesis; proposed mechanisms of arsenic toxicity carcinogenesis; redox regulation of gene expression and transcription factors in response to environmental oxidants. Target organs of environmental oxidants - lung: cigarette smoking and pulmonary oxidative damage; the health effects of diesel exhaust and diesel exhaust particles; the role of free radicals in asbestos- and silica-induced fibrotic lung diseases; reactive oxygen and silica-induced carcinogenesis; atmospheric oxidants and respiratory tract surfaces. Target organs of environmental oxidants - skin: redox modulation and oxidative stress in dermatotoxicology; dermatotoxicology of environmental and occupational hazards - agents and action; photo-oxidative stress in skin and regulation of gene expression; ozone induces stress in the skin barrier; immunotoxicology of oxidizing chemicals in the skin. Target organs of environmental oxidants - eye: environmental stressors and the eye - an overview; free radicals and ageing of anterior segment tissues of the eye; the role of ocular free radicals in age-related macular degeneration; nutritional influences on risk for cataract.

    1 in stock

    £454.91

  • IgE and AntiIgE Therapy in Asthma and Allergic

    Taylor & Francis Inc IgE and AntiIgE Therapy in Asthma and Allergic

    1 in stock

    Book SynopsisExploring the role of Immunoglobulin-E (IgE) in human disease, this reference summarizes current research on the mechanisms and utilization of anti-IgE therapeutics in the treatment of IgE-mediated allergic disease, inflammation, and asthma-discussing the structural composition of high- and low-affinity IgE receptors, the airway cells that express these receptors, and the functional activity of IgE-FceRI and IgE-FceRII interactions for improved control and management of allergic disorders.Compiles previously unpublished data from the first extensive scientific investigations of Xolair!IgE and Anti-IgE Therapy in Asthma and Allergic Diseasereviews studies on the distribution of serum IgE levels of normal and asthmatic populations in developed regions of the world such as the United States, Canada, Scandinavia, New Zealand, and Europe offers novel methods for the design and formulation of monoclonal antibodies discusses the use of allergeTable of Contents Introduction James D. Reimann, Sharon Safrin, and Robert B. Fick, Jr.Understanding the Binding of IgE to Its High-Affinity Receptor and to an Anti-IgE AntibodyLeonard G. Presta and Robert L. ShieldsMediator Release from Basophils and Mast Cells and Its Relationship to FceRI Expression and IgE-Suppressing TherapiesDonald W. MacGlashan, Jr., John T. Schroeder, Lawrence M. Lichtenstein, Sarbjit S. Saini, and Bruce S. BochnerExpression of IgE Receptors on Eosinophils David Dombrowicz, André Capron, and Monique CapronEosinophil IgE Receptors: Controversy and Consensus Hirohito Kita and Cheryl R. AdolphsonMurine Models of Asthma: Caveats and Conclusions on the Contribution of IgE and Mast Cells to Allergic Inflammation, Airway Hyperresponsiveness, and Airflow ObstructionJeffrey S. Tepper and Daniel B. TumasRole of IgE in Asthma: Pathogenesis and Novel Therapeutic StrategiesJames Laurence Lordan, Stephen T. Holgate, and Ian SayersIgE-Mediated Response to Allergen in the Bronchoprovocation LaboratoryLouis-Philippe Boulet and Donald W. CockcroftPathophysiology of the Airway Response to Inhaled Allergen in Asthmatic Subjects: Role of IgEJohn V. FahyEfficacy and Safety of Xolair Anti-IgE Monoclonal Antibody in Adult AsthmaticsRobert B. Fick, Jr., and W. James MetzgerThe Role of IgE in Pediatric Asthma Henry Milgrom and Charles JohnsonAnti-inflammatory Activities of Omalizumab (Xolair), a Recombinant Humanized Monoclonal Antibody Binding IgERobert B. Fick, Jr.Pulmonary Delivery of Anti-IgE: Rationale for Topical Delivery to the AirwayTheresa D. Sweeney, Melinda Marian, Jane Ruppel, and Jeanine L. BussiereTreatment of Seasonal Allergic Rhinitis Thomas B. Casale and Patricia W. RohaneAnti-IgE and Allergic Skin Diseases Michaël F. Hofer and Donald Y. M. LeungRole of IgE and Food Allergens Ricki M. Helm and A. Wesley BurksRole of IgE in Allergic Bronchopulmonary Aspergillosis Priscilla S. A. Sarinas and Rajinder K. ChitkaraIgE and Its Role in Parasitic Helminth Infection: Implications for Anti-IgE-Based TherapiesPhilip J. Cooper and Thomas B. NutmanThe Rise of Antibodies as Therapeutics Maureen P. Quan and Paul CarterAuthor Index

    1 in stock

    £175.00

  • Toxicologic Biomarkers

    Taylor & Francis Inc Toxicologic Biomarkers

    1 in stock

    Book SynopsisResponding to the explosion of advances in the use of biomarkers to efficiently, rapidly, and economically evaluate the health effects of chemical entities, this authoritative reference provides a detailed overview of the theory, development, and practical application of biomarkers in the toxicological, environmental, forensic, and pharmaceutical sciences. Compiling the most recent studies on the generation and utilization of biomarkers for toxicant exposure, environmental and human health risk assessment, occupational safety, drug development, and the detection of biological and chemical warfare agents, this guide supplies numerous examples, figures, tables, and comprehensive reference listings within each chapter to provide the reader with an in-depth understanding of the subject.Table of ContentsIntroduction to Toxicologic Biomarkers. Challenges in the Statistical Analysis of Biomarker Data. Biomarkers of Toxicant Exposure. Biomarkers in Environmental Epidemiology. Use of Biomarkers in Health Risk Assessment. Biomarkers of Toxicant Susceptibility. Identification and Use of Biomarkers in Preclinical Toxicologic Safety Assessment. Use of Biomarkers in Clinical Toxicology and Clinical Trials. Regulatory Guidance and Validation of Toxicologic Biomarkers. Use of Biomarkers in Occupational Safety and Health. Toxicogenomic and Toxicoproteomic Approaches for Biomarkers. Biomarkers of Chemical Warfare Agent Exposure. Applications of Biomarkers in Toxic Tort and Forensic Litigation

    1 in stock

    £171.00

  • Practical Pharmaceutical Laboratory Automation

    Taylor & Francis Inc Practical Pharmaceutical Laboratory Automation

    1 in stock

    Book SynopsisLaboratory automation is an increasingly important part of the job description of many laboratory scientists. Although many laboratory scientists understand the methods and principles involved in automation, most lack the necessary engineering and programming skills needed to successfully automate or interface equipment in the lab. A step-by-step, how-to reference and guide, Practical Pharmaceutical Laboratory Automation explores the processes needed to automate the majority of tasks required in research today. The author discusses topics ranging from automated mathematical analysis to robotic automation of chemical processes, to combinations of these and other processes. He presents a detailed discussion of high throughput screening and assay development and takes an in-depth look at Visual Basic as the primary programming language used in laboratories. The text has a dedicated web site (http://www.pharmalabauto.com) that contains all the sample code and examples contained witTable of ContentsIntroduction. Microsoft Excel Visual Basic Macros Running VBA Macros in Excel. Advanced Microsoft Excel VB Macro Techniques. Robotic Automation Using Visual Basic. Low Level Hardware Interfacing Using VB. Electronics for Automation. Robust Data Analysis Using Origin Lab's Origin. Agilent (HP) Chemstation Macro Writing. Appendices.

    1 in stock

    £175.00

  • Microbiological Assay For Pharmaceutical Analysis

    Taylor & Francis Inc Microbiological Assay For Pharmaceutical Analysis

    1 in stock

    Book SynopsisA user-friendly guide for the evaluation of microbiological assays, Microbiological Assay for Pharmaceutical Analysis: A Rational Approach provides a lucid explanation of the sources of error in microbiological assay and helps analysts choose efficient assay designs that will minimize those sources of error. Beginning with a review of the theoretical basis for the quantitative aspects, the author discusses microbiological assay as a branch of pharmaceutical analysis and distinguishes it from biological assay in general. He draws attention to the microbiological aspects that may not be so obvious to the chemical analyst and to the analytical aspects that may not be so obvious to the microbiologist. The book contains detailed evaluations of assays that illustrate typical experimental designs and addresses how to present a realistic assessment of the best potency estimate from a series of assays. Although there are other valuable books available in this area, they do not addressTable of ContentsMicrobiological Assay in Perspective. The Agar Diffusion Assay - Its Quantitative Basis. The Theory and Practice of Tube Assays for Growth Promoting Substances. The Theory and Practice of Tube Assays for Growth Inhibiting Substances. What Do We Want of an Assay? How Do We Attain Our Goal? General Practical Aspects of Microbiological Assays. Standard Reference Materials. Parallel Lines Assays - Some Designs and Their Evaluation. Slope Ratio Assays, Some Designs and Their Evaluation. Choice of Experimental Design. Concluding Thoughts.

    1 in stock

    £453.63

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account